Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2Phase NA 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Ovarian Neoplasms 7Lung Neoplasms 5Central Nervous System Neoplasms 5Retinoblastoma 4Neuroblastoma 4Uterine Cervical Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Testicular Neoplasms 2Spinal Cord Neoplasms 2Small Cell Lung Carcinoma 2Oligodendroglioma 2Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Endometrial Neoplasms 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2Adenocarcinoma of Lung 2Waldenstrom Macroglobulinemia 1Vomiting 1Triple Negative Breast Neoplasms 1Teratoma 1Stage IA Uterine Sarcoma 1Solid Tumor Cancer 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

Etoposide 1Electroacupuncture 1Carboplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ovarian Germ Cell Cancer × Carboplatin × Clear all
NCT00276718 2013-09-17

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
CNSGenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡